Forbes sells pharma assets, focuses on nutraceuticals
Forbes Medi-Tech confirmed yesterday that it is to sell its pharmaceutical assets, freeing up the company the focus on further developing its nutraceuticals business.
News, Analysis & Insights on Nutrition, Supplements, and Health
Forbes Medi-Tech confirmed yesterday that it is to sell its pharmaceutical assets, freeing up the company the focus on further developing its nutraceuticals business.
Consumers are frowning on moves by food manufacturers to reduce the size of products as a way of tackling shrinking budgets in the current economic climate, according to research by The Nielsen Company.
Flavanol-rich chocolate may boost blood flow in the brain and reduce the risk of dementia and stroke, Boston-based researchers have reported.
Cargill’s barley beta concentrate has received a heart health claim go-ahead, following the publication last week of a final ruling from the US Food and Drug Administration (FDA).